587 related articles for article (PubMed ID: 23413806)
1. The clinical utility of C-peptide measurement in the care of patients with diabetes.
Jones AG; Hattersley AT
Diabet Med; 2013 Jul; 30(7):803-17. PubMed ID: 23413806
[TBL] [Abstract][Full Text] [Related]
2. [The clinical utility of C-peptide measurement in diabetology].
Otto-Buczkowska E
Pediatr Endocrinol Diabetes Metab; 2015; 20(2):63-8. PubMed ID: 26615015
[TBL] [Abstract][Full Text] [Related]
3. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.
Jones AG; Besser RE; McDonald TJ; Shields BM; Hope SV; Bowman P; Oram RA; Knight BA; Hattersley AT
Diabet Med; 2011 Sep; 28(9):1034-8. PubMed ID: 21843301
[TBL] [Abstract][Full Text] [Related]
4. [The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children].
Szadkowska A; Pietrzak I; Markuszewski L; Bodalski J
Med Wieku Rozwoj; 2005; 9(2):223-34. PubMed ID: 16085963
[TBL] [Abstract][Full Text] [Related]
5. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
[TBL] [Abstract][Full Text] [Related]
6. C-peptide measurement: methods and clinical utility.
Bonser AM; Garcia-Webb P
Crit Rev Clin Lab Sci; 1984; 19(4):297-352. PubMed ID: 6373142
[TBL] [Abstract][Full Text] [Related]
7. C-peptide and residual β-cell function in pediatric diabetes - state of the art.
Jamiołkowska-Sztabkowska M; Głowińska-Olszewska B; Bossowski A
Pediatr Endocrinol Diabetes Metab; 2021; 27(2):123-133. PubMed ID: 34514768
[TBL] [Abstract][Full Text] [Related]
8. Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.
Bowman P; McDonald TJ; Shields BM; Knight BA; Hattersley AT
Diabet Med; 2012 Jan; 29(1):90-3. PubMed ID: 21883437
[TBL] [Abstract][Full Text] [Related]
9. [Serum and urine C-peptide and proinsulin to insulin ratio as an index for insulin secretion].
Sanke T
Nihon Rinsho; 2012 May; 70 Suppl 3():465-70. PubMed ID: 22768566
[No Abstract] [Full Text] [Related]
10. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes.
Saisho Y
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196896
[TBL] [Abstract][Full Text] [Related]
11. Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.
Hope SV; Jones AG; Goodchild E; Shepherd M; Besser RE; Shields B; McDonald T; Knight BA; Hattersley A
Diabet Med; 2013 Nov; 30(11):1342-8. PubMed ID: 23659458
[TBL] [Abstract][Full Text] [Related]
12. Variation of endogenous insulin secretion in association with treatment status: assessment by serum C-peptide and modified urinary C-peptide.
Aoki Y
Diabetes Res Clin Pract; 1991 Dec; 14(3):165-73. PubMed ID: 1778109
[TBL] [Abstract][Full Text] [Related]
13. C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.
Maddaloni E; Bolli GB; Frier BM; Little RR; Leslie RD; Pozzilli P; Buzzetti R
Diabetes Obes Metab; 2022 Oct; 24(10):1912-1926. PubMed ID: 35676794
[TBL] [Abstract][Full Text] [Related]
14. [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].
Gjessing HJ
Ugeskr Laeger; 1990 Feb; 152(9):588-93. PubMed ID: 2408222
[TBL] [Abstract][Full Text] [Related]
15. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes.
Thomas NJ; Lynam AL; Hill AV; Weedon MN; Shields BM; Oram RA; McDonald TJ; Hattersley AT; Jones AG
Diabetologia; 2019 Jul; 62(7):1167-1172. PubMed ID: 30969375
[TBL] [Abstract][Full Text] [Related]
16. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
Banerji MA
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
[TBL] [Abstract][Full Text] [Related]
17. Gastric inhibitory polypeptide (GIP): a therapeutic possibility?
Moody AJ; Jones IR; Krarup T; Owens DR; Saurbrey N
Acta Paediatr Scand Suppl; 1985; 320():66-71. PubMed ID: 3914816
[No Abstract] [Full Text] [Related]
18. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
[TBL] [Abstract][Full Text] [Related]
20. Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis.
Hope SV; Wienand-Barnett S; Shepherd M; King SM; Fox C; Khunti K; Oram RA; Knight BA; Hattersley AT; Jones AG; Shields BM
Br J Gen Pract; 2016 May; 66(646):e315-22. PubMed ID: 27080317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
